Noninvasive clinical staging modalities for lung cancer

Seminars in Surgical Oncology

Volumn 18, Issue 2, 2000, Pages 116-123

  Lau, Christine L ^a   Harpole Jr , David H ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adrenal gland neoplasms; Biopsy; Bone neoplasms secondary; Brain neoplasms secondary; Bronchoscopy; Computed tomography; Differential diagnosis; Emission computed tomography; False negative reactions; False positive reactions; Fluorodeoxyglucose; Lung neoplasms; Lymph nodes; Lymphatic metastasis; Neoplasm staging; Non small cell lung cancer; Postoperative complications; Preoperative care; Sensitivity and specificity; Survival rate

Indexed keywords

CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; LUNG CANCER; METASTASIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SYMPTOMATOLOGY; THORAX RADIOGRAPHY;

DIAGNOSTIC IMAGING; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM STAGING;

EID: 0033974627     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2388(200003)18:2<116::AID-SSU5>3.0.CO;2-L     Document Type: Review

References (76)

1. American Cancer Society: 1998 cancer facts and figures. Atlanta: American Cancer Society, 1998.
2. Denoix PF: [Enquete permanent dans les centres anticancereux]. Bull Inst Nat Hyg (Paris) 1946;1:70. (Fre)
3. Mountain CF: Revisions in the International System for Staging Lung Cancer. Chest 1997;111:1710-1717.
4. Pretreatment evaluation of non-small-cell lung cancer. American Thoracic Society and the European Respiratory Society. Am J Respir Crit Care Med 1997;156:320-332.
5. Hyde L, Hyde CI: Clinical manifestations of lung cancer. Chest 1974;65:299-306.
6. Lung cancer: perspectives and prospects [Review]. Ann Int Med 1970;73:1003-1024.
7. Lung cancer. In: Pearson FG, Deslauriers J, Ginsberg RJ, et al (eds): "Thoracic surgery." New York: Churchill Livingstone; 1995. p. 637-706.
8. D'Amico TA, David C, Sabiston J: Neoplasms of the lung: carcinoma of the lung. In: Sabiston DC, Spencer FC (eds): "Surgery of the chest." Vol. 1. Philadelphia: Saunders; 1995. p. 634-649.
9. Abrams HL, Sprio R, Goldstein N: Metastases in carcinoma: analysis of 1000 autopsied cases. Cancer 1950;3:74-85.
10. Ochsner A, DeBakey M: Carcinoma of the lung. Arch Surg 1941;42:209S-258S.
11. Carcinoma of the lung. In: Shields TW (ed): "General thoracic surgery." Vol. 1. Baltimore: Williams and Wilkins; 1994. p. 1095-1286.
12. Vinolas N, Molina R, Galan MC, et al: Tumor markers in response monitoring and prognosis of non-small cell lung cancer: preliminary report. Anticancer Research 1998; 18:631-634.
13. Rubins JB, Dunitz J, Rubins HB, et al: Serum carcinoembryonic antigen as an adjunct to preoperative staging of lung cancer. J Thorac Cardiovasc Surg 1998;116:412-416.
14. Icard P, Regnard JF, Essomba A, et al: Preoperative carcinoembryonic antigen level as a prognostic indicator in resected primary lung cancer. Ann Thorac Surg 1994;58:811-814.
15. Diez M, Torres A, Pollan M, et al: Prognostic significance of serum CA 125 antigen assay in patients with non-small cell lung cancer. Cancer 1994;73:1368-1376.
16. Wieskopf B, Demangeat C, Purohit A. et al: Cyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity and prognostic role. Chest 1995; 108:163-169.
17. Satoh H, Ishikawa H, Yamashita YT, et al: Predictive value of preoperative serum sialyl Lewis X-i antigen levels in non-small cell lung cancer. Anticancer Research 1998; 18:2865-2868.
18. Quinn DL, Ostrow LB, Porter DK, et al: Staging of non-small cell bronchogenic carcinoma. Relationship of the clinical evaluation to organ scan. Chest 1986;89:270-275.
19. Salvatierra A, Baamonde C, Llamas JM, et al: Extrathoracic staging of bronchogenic carcinoma. Chest 1990;97:1052-1058.
20. Kuriyama K, Tateishi R, Doi O, et al: CT-pathologic correlation in small peripheral lung cancers. AJR. Am J Roentgenol 1987;149: 1139-1143.
21. Kuhlman JE, Fishman EK, Kuhajda FP, et al: Solitary bronchioloalveolar carcinoma: CT criteria. Radiology 1988;167:379-382.
22. Zwirewich CV, Vedal S, Miller RR, Müller NL. Solitary pulmonary nodule: high-resolution CT and radiologie-pathologie correlation. Radiology 1991;179:469-476.
23. Higgins GA, Shields TW, Keehn RJ: The solitary pulmonary nodule. Arch Surg 1975;110:570-575.
24. Gurney JW: Determining the likelihood of malignancy in solitary pulmonary nodules with Bayesian analysis. Part I. Theory. Radiology 1993;186:405-413.
25. Zerhouni EA, Stitik FP, Siegelman SS, et al: CT of the pulmonary nodule: a cooperative study. Radiology 1986;160:319-327.
26. Sider L: Radiographic manifestations of primary bronchogenic carcinoma [Review]. Radiol Clin North Am 1990;28:583-597.
27. Theros EG: 1976 Caldwell lecture: varying manifestations of peripheral pulmonary neoplasms: a radiologic-pathologic correlative study [Review]. AJR. Am J Roentgenol 1977;128:893-914.
28. Swensen SJ, Brown LR, Colby TV, et al: Lung nodule enhancement at CT: prospective findings. Radiology 1996;201:447-455.
29. Yamashita K, Matsunobe S, Tsuda T, et al: Solitary pulmonary nodule: preliminary study of evaluation with incremental dynamic CT. Radiology 1995;194:399-405.
30. Milne EN: Pulmonary metastases: vascular supply and diagnosis. Int J Radiat Oncol Biol Phys 1976;1:739-742.
31. Zielinski KW, Kulig A: Morphology of the microvascular bed in primary human carcinomas of lung. Part I: Three-dimensional pattern of microvascular network. Pathol Res Pract 1984;178:243-250.
32. Milne EN, Zerhouni EA: Blood supply of pulmonary metastases. J Thorac Imaging 1987;2:15-23.
33. Dewan NA, Gupta NC, Redepenning LS, et al: Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Chest 1993;104:997-1002.
34. Ahuja V, Coleman RE, Herndon J, Patz EF Jr: The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma. Cancer 1998;83:918-924.
35. Duhaylongsod FG, Lowe VJ, Patz EF Jr, et al: Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography. Ann Thorac Surg 1995;60:1348-1352.
36. Patz EF Jr, Lowe VJ, Hoffman JM, et al: Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology 1993;188:487-490.
37. Gupta NC, Frank AR, Dewan NA, et al: Solitary pulmonary nodules: detection of malignancy with PET with 2-F-18-fluoro-2-deoxy-D-glucose. Radiology 1992;184:441-444.
38. Cook GJ, Maisey MN: The current status of clinical PET imaging [Review]. Clin Radiol 1996;51:603-613.
39. Lowe VJ, Duhaylongsod FG, Patz EF, et al: Pulmonary abnormalities and PET data analysis: a retrospective study. Radiology 1997;202:435-439.
40. Lowe VJ, Fletcher JW, Gobar L, et al: Prospective investigation of positron emission tomography in lung nodules (PIOPILN) . J Clin Oncol 1998;16:1075-1084.
41. Gupta NC, Maloof J, Gunel E: Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET. J Nucl Med 1996;37:943-948.
42. Erasmus JJ, McAdams HP, Patz EF Jr, et al: Thoracic FDG PET: state of the art [Review]. Radiographics 1998;18:5-20.
43. Higashi K, Ueda Y, Seki H, et al. Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma. J Nucl Med 1998;39:1016-1020.
44. Bury T, Paulus P, Dowlati A, et al: Evaluation of pleural diseases with FDG-PET imaging: preliminary report. Thorax 1997;52:187-189.
45. Daly BD Jr, Faling LJ, Bite G, et al: Mediastinal lymph node evaluation by computed tomography in lung cancer. J Thorac Cardiovasc Surg 1987;94:664-672.
46. Vallieres E, Waters PF: Incidence of mediastinal node involvement in clinical T1 bronchogenic carcinomas. Can J Surg 1987; 30:341-342.
47. Scott WJ, Schwabe JL, Gupta NC, et al: Positron emission tomography of lung tumors and mediastinal lymph nodes using [18F] fluorodeoxyglucose [Review]. Ann Thorac Surg 1994;58:698-703.
48. Scott WJ, Gobar LS, Hauser LG, et al: Detection of scalene lymph node metastases from lung cancer. Positron emission tomography [published erratum appears in Chest 1995;107:1776]. Chest 1995;107:1174-1176.
49. Wahl RL, Quint LE, Greenough RL, et al: Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. Radiology 1994;191:371-377.
50. Gambhir SS, Hoh CK, Phelps ME, et al: Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma. J Nucl Med 1996;37: 1428-1436.
51. Scott WJ, Gobar LS, Terry JD, et al: Mediastinal lymph node staging of non-small-cell lung cancer: a prospective comparison of computed tomography and positron emission tomography. J Thorac Cardiovasc Surg 1996;111:642-648.
52. Chin R, Ward R, Cappellari JC, et al: Mediastinal node (N2) involvement by PET-FDG scanning in non-small cell lung carcinoma (NSCLC): pathologic correlation. Chest 1994;106:89S.
53. Vansteenkiste JF, Stroobants SG, De Leyn PR, et al: Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer: a prospective analysis of 50 cases. Leuven Lung Cancer Group. Chest 1997;112:1480-1486.
54. Valk PE, Pounds TR, Hopkins DM, et al: Staging non-small cell lung cancer by whole-body positron emission tomographic imaging. Ann Thorac Surg 1995;60:1573-1582.
55. Pagani JJ: Non-small cell lung carcinoma adrenal metastases. Computed tomography and percutaneous needle biopsy in their diagnosis. Cancer 1984;53:1058-1060.
56. Porte HL, Roumilhac D, Graziana JP, et al: Adrenalectomy for a solitary adrenal metastasis from lung cancer. Ann Thorac Surg 1998;65:331-335.
57. Burt M, Heelan RT, Coit D, et al: Prospective evaluation of unilateral adrenal masses in patients with operable non-small-cell lung cancer. J Thorac Cardiovascul Surg 1994;107:584-589.
58. Klein JS, Webb WR: The radiologic staging of lung cancer [Review]. J Thorac Imaging 1991;7:29-47.
59. Oliver TW Jr, Bernardino ME, Miller JI, et al: Isolated adrenal masses in nonsmall-cell bronchogenic carcinoma. Radiology 1984;153:217-218.
60. Lee MJ, Hahn PF, Papanicolaou N, et al: Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. Radiology 1991;179:415-418.
61. McNicholas MM, Lee MJ, Mayo-Smith WW, et al: An imaging algorithm for the differential diagnosis of adrenal adenomas and metastases. AJR. Am J Roentgenol 1995;165:1453-1459.
62. Glazer GM, Woolsey EJ, Borrello J, et al: Adrenal tissue characterization using MR imaging. Radiology 1986;158:73-79.
63. Mitchell DG, Crovello M, Matteucci T, et al: Benign adrenocortical masses: diagnosis with chemical shift MR imaging. Radiology 1992;185:345-351.
64. Weder W, Schmid RA, Bruchhaus H, et al: Detection of extrathoracic metastases by positron emission tomography in lung cancer. Ann Thorac Surg 1998;66:886-893.
65. 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer. Lancet 1994;344(8932):1265-1266.
66. Erasmus JJ, Patz EF Jr, McAdams HP, et al: Evaluation of adrenal masses in patients with bronchogenic carcinoma by using 18F-fluorodeoxyglucose positron emission tomography. AJR. Am J Roentgenol 1997;168:1357-1360.
67. Marom EM, McAdams HP, Erasmus JJ, et al: Staging non-small cell lung cancer with whole-body PET. Radiology 1999;212: 803-809.
68. Bury T, Barreto A, Daenen F, et al: Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer . Eur J Nucl Med 1998;25:1244-1247.
69. Hustinx R, Paulus P, Jacquet N, et al: Clinical evaluation of whole-body 18F-fluorodeoxyglucose positron emission tomography in the detection of liver metastases. Ann Oncol 1998;9:397-401.
70. Hooper RG, Tenholder MF, Underwood GH, et al: Computed tomographic scanning of the brain in initial staging of bronchogenic carcinoma. Chest 1984;85:774-776.
71. Ramsdell JW, Peters RM, Taylor AT Jr, et al: Multiorgan scans for staging lung cancers. J Thorac Cardiovascul Surg 1977;73:653-659.
72. Grant D, Edwards D, Goldstraw P: Computed tomography of the brain, chest, and abdomen in the preoperative assessment of non-small cell lung cancer. Thorax 1988;43:883-886.
73. Sider L, Horejs D: Frequency of extrathoracic metastases from bronchogenic carcinoma in patients with normal-sized hilar and mediastinal lymph nodes on CT. AJR. Am J Roentgenol 1988;151: 893-895.
74. Arroliga AC, Matthay RA: The role of bronchoscopy in lung cancer [Review]. Clin Chest Med 1993;14:87-98.
75. Harrow EM, Wang KP: The staging of lung cancer by bronchoscopic transbronchial needle aspiration [review]. Chest Surg Clin North Am 1996;6:223-235.
76. Salazar AM, Westcott JL: The role of transthoracic needle biopsy for the diagnosis and staging of lung cancer. Clin Chest Med 1993;14:99-110.